Log In
Print this Print this

Augment Injectable Bone Graft (formerly GEM OS2)

  Manage Alerts
Collapse Summary General Information
Company Wright Medical Group Inc.
DescriptionCombination of recombinant human platelet derived growth factor BB (PDGFBB) and a beta-tricalcium phosphate/collagen matrix
Molecular Target Platelet derived growth factor receptor (PDGFR)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentRegistration
Standard IndicationBone repair
Indication DetailsTreat distal radial fractures that require fusion; Treat foot and ankle fusions
Regulatory Designation U.S. - Undisclosed Review (Treat foot and ankle fusions)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today